The tumor necrosis factor (TNF) inhibitors have been successfully used in the treatment of sarcoidosis, with improvement noted in recalcitrant cutaneous lesions.1- 2
Correspondence: Dr Rosenbach, Department of Dermatology, University of Pennsylvania, Maloney Bldg, 3600 Spruce St, Second Floor, Philadelphia, PA 19104 (misha.rosenbach@uphs.upenn.edu).
Financial Disclosure: Dr Rosenbach is an investigator for Centocor/Johnson & Johnson.
Funding/Support: This research was partially funded by a Dermatology Foundation Career Development Grant (Dr Rosenbach).